Orthopaedic Management of Gout

Area of Science:

• Rheumatology
• Orthopedics
• Crystal-induced Arthropathies

Background:

• Gout involves monosodium urate crystal deposition due to high uric acid levels.
• It is the most prevalent inflammatory arthritis in the U.S., frequently co-occurring with hypertension, obesity, and kidney disease.
• Gout commonly presents as acute joint inflammation, often in the big toe, but can affect other joints.

Purpose of the Study:

• To review the impact of gout on outcomes following total joint arthroplasty.
• To identify factors influencing arthroplasty results in patients with gout and its comorbidities.

Main Methods:

• Literature review of studies examining gout and total hip, knee, and ankle arthroplasty outcomes.
• Analysis of comorbidities associated with gout and their potential effects on surgical results.

Main Results:

• Gout does not appear to independently influence outcomes after total hip, knee, or ankle replacement.
• Comorbidities common in gout patients (hypertension, obesity, CKD) are significant factors affecting arthroplasty outcomes.
• Surgical intervention for gout is reserved for specific complications like soft tissue damage or infection.

Conclusions:

• Gout management focuses on controlling inflammation and uric acid levels.
• Pre-operative assessment and management of comorbidities are crucial for optimizing arthroplasty outcomes in gout patients.
• Further research may clarify the nuanced relationship between gout, its management, and joint replacement success.